Cargando…
Pretreatment Inflammatory Markers Predict Outcomes and Prognosis in Colorectal Cancer Patients With Synchronous Liver Metastasis
INTRODUCTION: Pretreatment inflammatory markers were applied to predict the prognosis of colorectal cancer. However, the role of these markers in predicting survival in patients with synchronous colorectal liver metastasis (CLM) is rarely reported. Notably, lymphocyte-to-monocyte ratio (LMR) was mai...
Autores principales: | Li, Qingfang, Chen, Linyan, Jin, Hongyu, Zhao, Yunuo, Hao, Zeng, Ma, Xuelei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958682/ https://www.ncbi.nlm.nih.gov/pubmed/35355514 http://dx.doi.org/10.1177/11795549221084851 |
Ejemplares similares
-
Proteomic Analysis of Cerebrospinal Fluid From Patients With Extranodal NK-/T-Cell Lymphoma of Nasal-Type With Ethmoidal Sinus Metastasis
por: Li, Qingfang, et al.
Publicado: (2020) -
Do inflammatory markers predict prognosis in patients with synchronous colorectal cancer?
por: He, Wanbin, et al.
Publicado: (2017) -
Pretreatment Inflammatory Indexes as Prognostic Predictors of Survival in Patients Suffering From Synovial Sarcoma
por: Cheng, Yuan, et al.
Publicado: (2019) -
Pretreatment inflammatory markers predicting treatment outcomes in colorectal cancer
por: An, Sanghyun, et al.
Publicado: (2022) -
T1 Colorectal Cancer with Synchronous Liver Metastasis
por: Sugimoto, Kiichi, et al.
Publicado: (2013)